Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 4
2017 3
2018 5
2019 2
2020 2
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, Briganti A, Budäus L, Hellawell G, Hindley RG, Roobol MJ, Eggener S, Ghei M, Villers A, Bladou F, Villeirs GM, Virdi J, Boxler S, Robert G, Singh PB, Venderink W, Hadaschik BA, Ruffion A, Hu JC, Margolis D, Crouzet S, Klotz L, Taneja SS, Pinto P, Gill I, Allen C, Giganti F, Freeman A, Morris S, Punwani S, Williams NR, Brew-Graves C, Deeks J, Takwoingi Y, Emberton M, Moore CM; PRECISION Study Group Collaborators. Kasivisvanathan V, et al. Among authors: venderink w. N Engl J Med. 2018 May 10;378(19):1767-1777. doi: 10.1056/NEJMoa1801993. Epub 2018 Mar 18. N Engl J Med. 2018. PMID: 29552975 Free PMC article. Clinical Trial.
The utility of in-bore multiparametric magnetic resonance-guided biopsy in men with negative multiparametric magnetic resonance-ultrasound software-based fusion targeted biopsy.
Perrin A, Venderink W, Patak MA, Möckel C, Fehr JL, Jichlinski P, Porcellini B, Lucca I, Futterer J, Valerio M. Perrin A, et al. Among authors: venderink w. Urol Oncol. 2021 May;39(5):297.e9-297.e16. doi: 10.1016/j.urolonc.2020.11.041. Epub 2020 Dec 17. Urol Oncol. 2021. PMID: 33341358 Free article.
15 results